These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9847965)

  • 1. Pulmonary eosinophilia associated with aminoglutethimide.
    Bell SC; Anderson EG
    Aust N Z J Med; 1998 Oct; 28(5):670-1. PubMed ID: 9847965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aminoglutethimide in the treatment of metastatic breast carcinoma].
    Vasović S; Nesković-Konstantinović Z; Susnjar S; Stamatović Lj; Nesković B; Mitrović L; Jelić S
    Srp Arh Celok Lek; 1999; 127(9-10):333-7. PubMed ID: 10649904
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminoglutethimide-induced bone marrow injury. Report of a case and review of the literature.
    Young JA; Newcomer LN; Keller AM
    Cancer; 1984 Oct; 54(8):1731-3. PubMed ID: 6478412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
    Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
    J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglutethimide-induced myelosuppression.
    van der Heijden JT; Splinter TA
    Breast Cancer Res Treat; 1986; 7(3):211-2. PubMed ID: 3779118
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminoglutethimide-induced hyperkalaemia.
    Davies JP; Bentley P; Ghose RR
    Br J Clin Pract; 1989 Jul; 43(7):263-4. PubMed ID: 2597612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transient bone marrow inhibition caused by aminoglutethimide].
    Tel W; van Lijf JH; ten Napel CH
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):126-8. PubMed ID: 2922066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.
    Wong PW; Macris N; DiFabrizio L; Seriff NS
    Chest; 1998 Feb; 113(2):548-50. PubMed ID: 9498983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group.
    Thürlimann B; Paridaens R; Serin D; Bonneterre J; Roché H; Murray R; di Salle E; Lanzalone S; Zurlo MG; Piscitelli G
    Eur J Cancer; 1997 Oct; 33(11):1767-73. PubMed ID: 9470830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
    Friedrichs K; Jänicke F
    Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer.
    Vincent MD; Clink HM; Coombes RC; Smith IE; Kandler R; Powles TJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):105-6. PubMed ID: 2990631
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G; Biran S
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
    Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
    Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
    Brufman G; Biran S
    Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
    Lawrence B; Santen RJ; Lipton A; Harvey HA; Hamilton R; Mercurio T
    Cancer Treat Rep; 1978 Oct; 62(10):1581-3. PubMed ID: 213192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia after combination therapy with aminoglutethimide and tamoxifen: which drug is to blame?
    Ragaz J; Buskard N; Manji M
    Cancer Treat Rep; 1984; 68(7-8):1015-6. PubMed ID: 6744333
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of metastasizing breast cancer with aminoglutethimide].
    Kübböck J; Ludwig H; Aiginger P; Linkesch W; Pötzi P
    Acta Med Austriaca; 1982; 9(5-6):221-6. PubMed ID: 7164757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aminoglutethimide in metastasizing carcinoma of the breast resistant to hormonal and cytostatic treatment (author's transl)].
    Rieche K
    Dtsch Med Wochenschr; 1981 Oct; 106(40):1296-300. PubMed ID: 7274074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglutethimide induced agranulocytosis in breast cancer.
    Caldwell G; Bradbury A; Toft AD
    Br Med J (Clin Res Ed); 1985 Oct; 291(6500):970-1. PubMed ID: 3929986
    [No Abstract]   [Full Text] [Related]  

  • 20. A call for caution in the use of aminoglutethimide: negative interactions with dexamethasone and beta blocker treatment.
    Halpern J; Catane R; Baerwald H
    J Med; 1984; 15(1):59-63. PubMed ID: 6149250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.